The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Mark O'Driscoll sits on this spectrum.
This scientist: 83 publications — 3rd percentile
3% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 703 publications or more.
The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Mark O'Driscoll sits on this spectrum.
This scientist: 42 D-Index — 1st percentile
1% of scientists in this discipline score the same or lower.
The last bar groups every scientist with 160 D-Index or more.
Mark O'Driscoll is affiliated with the University of Sussex in the United Kingdom and has contributed to research primarily within the fields of Biochemistry, Genetics and Molecular Biology, and Medicine. Their work encompasses several subfields including Molecular Biology, Genetics, Oncology, Clinical Biochemistry, and Immunology.
The scientist's research topics cover a range of areas: signaling pathways in disease, PARP inhibition in cancer therapy, genetics and neurodevelopmental disorders, metabolism and genetic disorders, mitochondrial function and pathology, blood disorders and treatments, as well as immunodeficiency and autoimmune disorders.
Notable recent publications by Mark O'Driscoll include:
• "DTYMK is essential for genome integrity and neuronal survival" (2021), published in Acta Neuropathologica
• "Homozygous DBF4 mutation as a cause of severe congenital neutropenia" (2023), published in Journal of Allergy and Clinical Immunology
• "A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex" (2024), published in EMBO Reports
• "The "extreme phenotype approach" applied to male breast cancer allows the identification of rare variants of ATR as potential breast cancer susceptibility alleles" (2023), published in Oncotarget
• "A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex" (2023), published in bioRxiv (Cold Spring Harbor Laboratory)
The scientist frequently collaborates with several coauthors including Rita Colnaghi, Marisa Bedir, Emily Outwin, Lydia Bassett, and I Abramowiçz.
Mark O'Driscoll's work has appeared in various publication venues including Acta Neuropathologica, Journal of Allergy and Clinical Immunology, EMBO Reports, Oncotarget, and bioRxiv (Cold Spring Harbor Laboratory).
Tom Stiff;Mark O’Driscoll;Nicole Rief;Kuniyoshi Iwabuchi
Mark O'Driscoll;Victor L Ruiz-Perez;C Geoffrey Woods;Penny A Jeggo
Mark O'Driscoll;Penny A. Jeggo
Jean Baptiste Rivière;Ghayda M. Mirzaa;Brian J. O'Roak;Margaret Beddaoui
Mark O'Driscoll;Karen M. Cerosaletti;Pierre M. Girard;Yan Dai
Thomas Stiff;Sarah A Walker;Karen Cerosaletti;Aaron A Goodarzi
Elen Griffith;Sarah Walker;Carol-Anne Martin;Paola Vagnarelli
M. Bignami;M. O'Driscoll;G. Aquilina;P. Karran
Thomas Stiff;Caroline Reis;Gemma K Alderton;Lisa Woodbine
Gemma K. Alderton;Hans Joenje;Raymonda Varon;Anders D. Børglum
Louise S. Bicknell;Sarah Walker;Anna Klingseisen;Tom Stiff
Mark O'Driscoll;A. R. Gennery;J Seidel;P. Concannon
Gemma K Alderton;Laura Galbiati;Elen Griffith;Kathatrina H Surinya
David A. Dyment;Amanda C. Smith;Diana Alcantara;Jeremy A. Schwartzentruber
Mark O’Driscoll
Laura M McDonell;Ghayda M Mirzaa;Diana Alcantara;Jeremy Schwartzentruber
Rita Colnaghi;Gillian Carpenter;Marcel Volker;Mark O'Driscoll
Felicity Payne;Rita Colnaghi;Nuno Rocha;Asha Seth
Tomoo Ogi;Sarah Walker;Tom Stiff;Emma Hobson
Mark O’Driscoll;Penny A. Jeggo
If you think any of the details on this page are incorrect, let us know.
Studying Genetics in the USA opens doors to a range of related online degrees and career pathways. For those interested in the administrative side of healthcare, online medical coding programs offer a practical stepping stone into genetics data management and healthcare informatics.
Many students now choose accelerated programs to fast-track their entry into the workforce or progress rapidly toward advanced roles. These programs allow you to earn your degree in less time, making them attractive for career changers or motivated students aiming to specialize in genetics sooner.
Flexibility is another key advantage. Self paced degrees are ideal for those balancing work, life, and studies, allowing you to learn at your own speed and schedule.
Choosing a college can also be more accessible, thanks to colleges with no application fee. This reduces upfront costs and encourages more students to apply to leading online genetics and healthcare programs.
University of Sheffield
University of California, Davis
National Research Council (CNR)
University of Florida
Woods Hole Oceanographic Institution
University of Southern California
University of Wisconsin–Madison
Aerodyne Research
Monterey Bay Aquarium Research Institute
Roswell Park Cancer Institute
North-West University
Chinese Academy of Sciences
The Ohio State University
Louisiana State University
University of Oxford
Xi'an Jiaotong University
